Skip to main content
Caplight Logo









Nuclivision

Nuclivision

Private
BelgiumEnterprise Softwarehttps://www.nuclivision.com/

Last Round

Seed

Apr 24, 2025

Total Funding Raised

$5.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nuclivision is a healthtech company that develops AI-powered software, Nuclarity, designed to enhance PET imaging by reducing scan times and radiation exposure.

Sector

Enterprise Software

Verticals

Marketing, Digital Advertising, Content Creation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medical imaging softwarePET scan enhancementAI medical imagingMedTechsoftware as a medical deviceSaMDclinical workflow automationnuclear medicinediagnostic imagingAI healthcareclinical softwareISO 13485health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuclivision Comparables

Compare Nuclivision with similar companies based on industry and business-model similarity.

Nuclivision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Claritas HealthTech
30%

Nuclivision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 24, 2025

Key People

Founding team and executive leadership

Tomas Brants

Cofounder COO

Founding Team

Nuclivision Investors

Notable investors and investment history

Nuclivision investors
InvestorRounds
LUMO LabsSeed
imec.istartPre Seed
HERAN PartnersSeed
Imec.iStartSeed
LumiaresPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 21, 95% of headcount.

  • Jul 13, 2026

    Open roles increased to 14, 2.5x the trailing average.

Nuclivision Filings

Explore SEC and related filing metadata, where available.

Nuclivision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nuclivision's valuation, stock price, and market status.

Is Nuclivision a public or private company?

Nuclivision is a private company.

What is the current stock price of Nuclivision?

Nuclivision is a private company with no public stock price. No recent secondary market data is available.

How much is Nuclivision worth (valuation)?

Valuation information for Nuclivision is not publicly available.

Can I buy Nuclivision stock?

Nuclivision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nuclivision's last funding round?

Nuclivision's most recent funding round was Seed on April 24, 2025.

Who are the main investors in Nuclivision?

Key investors in Nuclivision include LUMO Labs, HERAN Partners.

Will Nuclivision IPO soon?

No public IPO plans have been announced for Nuclivision.

How can I track Nuclivision secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuclivision's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelgium
Employee Range15
Year Founded2022
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?